Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jun 5;155(1-3):11-7.
doi: 10.1016/j.regpep.2009.03.012. Epub 2009 Apr 2.

Opioid receptors in the gastrointestinal tract

Peter Holzer  1
Affiliations
Review

Opioid receptors in the gastrointestinal tract

Peter Holzer. Regul Pept. .

Abstract

Opium is arguably one of the oldest herbal medicines, being used as analgesic, sedative and antidiarrheal drug for thousands of years. These effects mirror the actions of the endogenous opioid system and are mediated by the principal mu-, kappa- and delta-opioid receptors. In the gut, met-enkephalin, leu-enkephalin, beta-endorphin and dynorphin occur in both neurons and endocrine cells. When released, opioid peptides activate opioid receptors on the enteric circuitry controlling motility and secretion. As a result, inhibition of gastric emptying, increase in sphincter tone, induction of stationary motor patterns and blockade of peristalsis ensue. Together with inhibition of ion and fluid secretion, these effects cause constipation, one of the most frequent and troublesome adverse reactions of opioid analgesic therapy. Although laxatives are most frequently used to ameliorate opioid-induced bowel dysfunction, their efficacy is unsatisfactory. Specific antagonism of peripheral opioid receptors is a more rational approach. This goal is addressed by the use of opioid receptor antagonists with limited absorption such as oral prolonged-release naloxone and opioid receptor antagonists that do not penetrate the blood-brain barrier such as methylnaltrexone and alvimopan. Preliminary evidence indicates that peripherally restricted opioid receptor antagonists may act as prokinetic drugs in their own right.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Overview of the gastrointestinal opioid system.
Fig. 2
Fig. 2
Nonspecific and specific management of opioid-induced bowel dysfunction.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Holzer P, Lembeck F. Analgesia up to the twentieth century. In: Parnham MJ, Bruinvels, editors. Discoveries in Pharmacology. Psycho- and Neuro-pharmacology. Elsevier; Amsterdam: 1983. pp. 357–77.
    1. Hamilton GR, Baskett TF. In the arms of Morpheus: the development of morphine for postoperative pain relief. Can J Anaesth. 2000;47:367–74. - PubMed
    1. Lammers WJ, Lammers-van den Berg AM, Morrison JF, Petroianu GA. Translating Trendelenburg; back to the future. Naunyn Schmiedebergs Arch Pharmacol. 2006;373:134–8. - PubMed
    1. Trendelenburg P. Physiological and pharmacological investigations of small intestinal peristalsis. Arch Exp Pathol Pharmakol. 1917;81:55–129. [Translation of the article “Physiologische und pharmakologische Versuche über die Dünndarmperistaltik”] - PubMed
    2. Naunyn-Schmiedeberg’s Arch Pharmacol. 1917;373:101–33. - PubMed
    1. Schaumann O. Pain, the protective system and combinations with morphine-like effect. Wien Med Wschr. 1959;109:78–81. - PubMed

Publication types

MeSH terms